CA2606875C - Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone - Google Patents

Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone Download PDF

Info

Publication number
CA2606875C
CA2606875C CA2606875A CA2606875A CA2606875C CA 2606875 C CA2606875 C CA 2606875C CA 2606875 A CA2606875 A CA 2606875A CA 2606875 A CA2606875 A CA 2606875A CA 2606875 C CA2606875 C CA 2606875C
Authority
CA
Canada
Prior art keywords
antibiotic
therapeutically active
ionone
amoxicillin
carveol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2606875A
Other languages
English (en)
French (fr)
Other versions
CA2606875A1 (fr
Inventor
Adnane Remmal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Scientific Developments
Original Assignee
Advanced Scientific Developments
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scientific Developments filed Critical Advanced Scientific Developments
Publication of CA2606875A1 publication Critical patent/CA2606875A1/fr
Application granted granted Critical
Publication of CA2606875C publication Critical patent/CA2606875C/fr
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2606875A 2005-05-13 2006-05-15 Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone Active CA2606875C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB2005/001313 WO2006120494A1 (fr) 2005-05-13 2005-05-13 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol
IBPCT/IB2005/001313 2005-05-13
PCT/IB2006/001350 WO2006120567A2 (fr) 2005-05-13 2006-05-15 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol

Publications (2)

Publication Number Publication Date
CA2606875A1 CA2606875A1 (fr) 2006-11-16
CA2606875C true CA2606875C (fr) 2015-12-15

Family

ID=35427275

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2606875A Active CA2606875C (fr) 2005-05-13 2006-05-15 Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone

Country Status (13)

Country Link
US (1) US20080214518A1 (https=)
EP (1) EP1879655B1 (https=)
JP (1) JP5410748B2 (https=)
CN (3) CN103356612B (https=)
BR (1) BRPI0610125B8 (https=)
CA (1) CA2606875C (https=)
DK (1) DK1879655T3 (https=)
EA (1) EA014069B1 (https=)
ES (1) ES2530963T3 (https=)
MA (1) MA29606B1 (https=)
PT (1) PT1879655E (https=)
TN (1) TNSN07424A1 (https=)
WO (2) WO2006120494A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918571B1 (fr) * 2007-07-10 2013-01-11 Aroma Tech Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales
ES2716474T3 (es) * 2007-10-26 2019-06-12 Avivagen Inc Composiciones y métodos para mejorar la respuesta inmunitaria
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
EA019746B1 (ru) 2009-09-24 2014-05-30 Юнилевер Нв Противомикробная композиция, содержащая эвгенол, терпинеол и тимол, и способ дезинфицирования поверхности
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition
BR112014013601B1 (pt) 2011-12-06 2020-04-14 Unilever N.V. composições antimicrobianas, método não terapêutico para desinfetar uma superfície e usos não terapêuticos de uma composição
CN102670598B (zh) * 2012-05-08 2014-07-16 广东药学院 一种青霉素冰片组合物在制备抗菌药物中的应用
CN102670619B (zh) * 2012-05-08 2014-02-19 广东药学院 一种头孢氨苄冰片组合物
CN103146255B (zh) * 2013-02-25 2014-07-09 厦门吉宏包装科技有限公司 一种抑菌驱螨印刷底油母液和由母液制作的印刷底油及其制备方法
EP2993985A4 (en) * 2013-05-07 2016-10-05 Kemin Ind Inc ANTIMICROBIAL COMPOSITIONS WITH CARVACROL AND THYMOL
FR3025719A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
FR3025718A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
WO2016081594A1 (en) * 2014-11-19 2016-05-26 The General Hospital Corporation System and method for photo-dynamic procedure
HUE052575T2 (hu) * 2014-12-18 2021-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
EP3233069A1 (en) * 2014-12-18 2017-10-25 Helperby Therapeutics Limited Antimicrobial combinations and their use in the treatment of microbial infection
CN106377757B (zh) * 2016-03-04 2020-05-19 广州英赛特生物技术有限公司 含氧碳氢衍生物作为多粘菌素的协同增效剂的应用
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
WO2017209588A2 (fr) 2016-06-02 2017-12-07 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
GB201904963D0 (en) * 2019-04-08 2019-05-22 Anpario Plc Composition for reducing antimicrobial resistance
US12460153B2 (en) 2019-12-04 2025-11-04 Pranarom International S.A. Method for transforming an essential oil
KR102848354B1 (ko) * 2023-02-13 2025-08-21 경상국립대학교산학협력단 테트라사이클린계 항생제와 시너지 효과를 가지는 바닐린 또는 카바크롤을 유효성분으로 포함하는 조성물 및 이의 용도

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317775A (en) * 1980-01-07 1982-03-02 Hoffmann-La Roche Inc. Amoxicillin derivatives
US5213615A (en) * 1986-10-11 1993-05-25 Ivoclar Ag Dental material and method for the control of caries and paradentitis
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
US5801153A (en) * 1991-09-13 1998-09-01 Badaway; Mohammed A. Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
US5308873A (en) * 1992-12-18 1994-05-03 Doyle E. Chastain Method of killing yeast and fungi with carveol
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US6319507B1 (en) * 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
US6025400A (en) * 1998-08-24 2000-02-15 Marco Polo Technologies Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the same
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6495512B1 (en) * 2000-06-23 2002-12-17 International Flavors & Fragrances Inc. Salicylaldehyde-containing composition having antimicrobial and fragrancing properties and process for using same
WO2002028382A1 (en) * 2000-10-06 2002-04-11 Van Beek, Ron Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030180349A1 (en) * 2001-12-07 2003-09-25 Franklin Lanny U. Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004045572A1 (en) * 2002-11-21 2004-06-03 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
AU2003296937A1 (en) * 2002-12-10 2004-06-30 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
ES2461178T3 (es) * 2004-05-20 2014-05-19 Eden Research Plc Partícula hueca de glucano o de pared celular que encapsula un componente de terpeno

Also Published As

Publication number Publication date
EA200702483A1 (ru) 2008-04-28
BRPI0610125B8 (pt) 2021-05-25
DK1879655T3 (en) 2015-02-23
CN101175531B (zh) 2011-09-07
JP2008540507A (ja) 2008-11-20
JP5410748B2 (ja) 2014-02-05
US20080214518A1 (en) 2008-09-04
CA2606875A1 (fr) 2006-11-16
WO2006120567A2 (fr) 2006-11-16
WO2006120494A1 (fr) 2006-11-16
CN102319246B (zh) 2013-07-17
PT1879655E (pt) 2015-02-24
MA29606B1 (fr) 2008-07-01
EA014069B1 (ru) 2010-08-30
ES2530963T3 (es) 2015-03-09
CN103356612B (zh) 2015-04-15
WO2006120567A3 (fr) 2007-08-23
CN101175531A (zh) 2008-05-07
EP1879655B1 (fr) 2014-11-26
EP1879655A2 (fr) 2008-01-23
BRPI0610125B1 (pt) 2020-08-11
CN102319246A (zh) 2012-01-18
BRPI0610125A2 (pt) 2012-09-25
TNSN07424A1 (fr) 2009-03-17
CN103356612A (zh) 2013-10-23

Similar Documents

Publication Publication Date Title
CA2606875C (fr) Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone
EP2437737B1 (fr) Composition comprenant au moins du trans-cinnamaldehyde et son utilisation dans le traitement des infections bacteriennes plus particulierement dans le traitement des maladies nosocomiales
FR2918571A1 (fr) Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales
EP1879654B1 (fr) Combinaison pharmaceutique comprenant un agent antifongique et un actif qui est notamment l'eugénol ou le carvacrol
EP3193936B1 (fr) Antimicrobiens potentialises
EP3463479A2 (fr) Formulation pharmaceutique de cinéol et d'amoxicilline
FR3028180A1 (fr) Nouvelles compositions aux proprietes biocides comprenant des composes extraits de plantes tropicales
EP2696862A1 (fr) Utilisation de calixarenes dans le traitement des infections bacteriennes
EP3429579B1 (fr) Tulathromycine potentialisee
CA2664124A1 (fr) Nouvelle classe de composes derives de terpene a activite antibiotique, compositions les contenant et utilisations
FR3052065B1 (fr) Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne
EP1902721A1 (fr) Compositions médicales et nutritionnelles à base de vaccinium macrocarpon
FR3052066B1 (fr) Formulation pharmaceutique de cineol et d'amoxicilline
EP3193860A1 (fr) Antimicrobiens potentialises
CA3079023A1 (fr) Utilisation de la cloxacilline pour inhiber/empecher la formation de biofilm
FR3072022A1 (fr) Composition pharmaceutique pour controler helicobacter pylori
FR2906243A1 (fr) Nouvelle classe de composes derives de terpene a activite antibiotique, compositions les contenants et utilisations

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 19TH ANNIV.) - STANDARD

Year of fee payment: 19

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250512

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250512